TORONTO, ONTARIO--(Marketwired - March 3, 2017) - Effective immediately the shares of Abattis Bioceuticals Corp. will be reinstated for trading.

The Company has rectified the default situation that gave rise to the suspension.

Effective Date: March 3, 2017

Symbol: ATT

Contact Information:

Canadian Securities Exchange (CSE)
Listings
(416) 367-7340
Listings@thecse.com
www.thecse.com